Ultrasound MIST Therapy
Low-frequency ultrasound through a saline mist — non-contact debridement that patients tolerate remarkably well.
Overview
The Qoustic Wound Therapy System™ (Arobella Medical) delivers 35 kHz low-frequency ultrasound through a fine saline mist, debriding nonviable tissue and disrupting bacterial biofilm without instrument contact. The acoustic energy stimulates cellular activity, improves local circulation, and calms inflammation — an FDA-cleared modality (K062544, K131096) for wounds from diabetic foot ulcers to osteomyelitis. Treatment courses typically run up to three sessions weekly over two or more weeks at physician direction.
Distinctions
- 35 kHz low-frequency ultrasound via saline mist
- Non-contact debridement of nonviable tissue
- Disrupts biofilm; reduces bacterial burden
- Stimulates circulation and cellular repair
- FDA-cleared: K062544, K131096
Clinical Indications
Acute and chronic wound debridement; diabetic foot ulcers; pressure and venous insufficiency ulcers; burns; surgical wounds; osteomyelitis; fistulas; infected or devitalized tissue.
Considerations
Physician-directed; maximum three treatments weekly.
Sizes & Reference Codes
| Reference | Size / Format |
|---|---|
| Qoustic Wound Therapy System™ | 35 kHz ultrasound + saline mist |
Also In Advanced Therapies
Complete the category.
Negative Pressure Wound Therapy
Controlled suction at the wound bed — removing drainage, debris, and infectious material while tissue rebuilds.
Product Details
PRP Wound Gel
The patient's own platelets, concentrated into a moldable healing gel at the point of care.
Product Details